Parhofer, Klaus G : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (157)
Les plus populaires
Liste
- Liste
- Tableau

1

Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events

Jaeger, Beate R, Richter, Yvonne, Nagel, Dorothea, Heigl, Franz, Vogt, Anja, Roeseler, Eberhard, Parhofer, Klaus, Ramlow, Wolfgang, Koch, Michael, Utermann, Gerd, Labarrere, Carlos A, Seidel, Dietrich

Journal:

Nature Clinical Practice Cardiovascular Medicine

Année:

2009

Langue:

english

Fichier:

PDF, 209 KB

english, 2009

2

Prevalence and sociodemographic determinants of adult obesity: a large representative household survey in a resource-constrained African setting with double burden of undernutrition and overnutrition

Chigbu, Chibuike Ogwuegbu, Parhofer, Klaus G, Aniebue, Uzochukwu U, Berger, Ursula

Journal:

Journal of Epidemiology & Community Health

Année:

2018

Langue:

english

Fichier:

PDF, 191 KB

english, 2018

3

Head-to-head comparison of an automated immunometric and an automated HPLC method for the quantification of HbA1c

Michael Vogeser, Klaus G. Parhofer

Journal:

Clinical Biochemistry

Année:

2008

Langue:

english

Fichier:

PDF, 229 KB

english, 2008

4

Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects

Hans C. Geiss, Carsten Otto, Peter Schwandt, Klaus G. Parhofer

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 101 KB

english, 2001

5

Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo

Jochen G Schneider, Max von Eynatten, Klaus G Parhofer, Jan E Volkmer, Stephan Schiekofer, Andreas Hamann, Peter P Nawroth, Klaus A Dugi

Journal:

Atherosclerosis

Année:

2004

Langue:

english

Fichier:

PDF, 81 KB

english, 2004

6

Bowel habits and bile acid malabsorption in the months after cholecystectomy

Gerd H Sauter, Ahmed C Moussavian, Guenther Meyer, Heinrich O Steitz, Klaus G Parhofer, Dieter Jüngst

Journal:

American Journal of Gastroenterology

Année:

2002

Langue:

english

Fichier:

PDF, 62 KB

english, 2002

7

Atorvastatin Improves Postprandial Lipoprotein Metabolism in Normolipidemic Subjects 1

Parhofer, Klaus G., Barrett, P. Hugh R., Schwandt, Peter

Journal:

Journal of Clinical Endocrinology & Metabolism

Année:

2000

Langue:

english

Fichier:

PDF, 165 KB

english, 2000

8

Lipoprotein(a): Medical Treatment Options for an Elusive Molecule

G. Parhofer, Klaus

Journal:

Current Pharmaceutical Design

Année:

2011

Langue:

english

Fichier:

PDF, 106 KB

english, 2011

9

So steuern Sie das Essverhalten Ihrer Patienten in die richtige Richtung

Lechner, Katharina, Parhofer, Klaus G.

Journal:

MMW - Fortschritte der Medizin

Année:

2016

Langue:

german

Fichier:

PDF, 515 KB

german, 2016

10

Die Verordnung von PCSK9-Inhibitoren ist klar geregelt; PCSK9 inhibitors: For which patients? For which indication? What to consider?;

Busygina, Kristina, Parhofer, Klaus G.

Journal:

MMW - Fortschritte der Medizin

Année:

2018

Langue:

german

Fichier:

PDF, 177 KB

german, 2018

11

A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial

Bamberger, Charlotte, Rossmeier, Andreas, Lechner, Katharina, Wu, Liya, Waldmann, Elisa, Fischer, Sandra, Stark, Renée, Altenhofer, Julia, Henze, Kerstin, Parhofer, Klaus

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 2.55 MB

english, 2018

12

Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a)

Waldmann, Elisa, Parhofer, Klaus G.

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 687 KB

english, 2019

13

Lipidstoffwechselstörungen und deren Behandlung bei Diabetes mellitus; Dyslipidemias and their treatment in diabetes mellitus;

Parhofer, Klaus G.

Journal:

Der Diabetologe

Année:

2019

Langue:

german

Fichier:

PDF, 135 KB

german, 2019

14

PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice

Parhofer, Klaus G., von Stritzky, Berndt, Pietschmann, Nicole, Dorn, Cornelia, Paar, W. Dieter

Journal:

Drugs - Real World Outcomes

Année:

2019

Langue:

english

Fichier:

PDF, 860 KB

english, 2019

15

Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease

Uli C. Broedl, Veronika Schachinger, Arno Lingenhel, Michael Lehrke, Renee Stark, Frank Seibold, Burkhard Göke, Florian Kronenberg, Klaus G. Parhofer, Astrid Konrad-Zerna

Journal:

Inflammatory Bowel Diseases

Année:

2007

Langue:

english

Fichier:

PDF, 92 KB

english, 2007

16

The effects of three different LDL-apheresis methods on the plasma concentrations of E-selectin, VCAM-1, and ICAM-1

Klaus Empen, Carsten Otto, Uli C. Brödl, Klaus G. Parhofer

Journal:

Journal of Clinical Apheresis

Année:

2002

Langue:

english

Fichier:

PDF, 114 KB

english, 2002

17

Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis—Comparison of performance characteristics with DALI and lipidfiltration

Ulrich Julius, Klaus G. Parhofer, Andreas Heibges, Stefan Kurz, Reinhard Klingel, Hans-Christian Geiss

Journal:

Journal of Clinical Apheresis

Année:

2007

Langue:

english

Fichier:

PDF, 162 KB

english, 2007

18

Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia

Carsten Otto, Jutta Berster, Bärbel Otto, Klaus G. Parhofer

Journal:

Journal of Clinical Apheresis

Année:

2007

Langue:

english

Fichier:

PDF, 98 KB

english, 2007

19

BMI and hyperinsulinemia in children

Michael Vogeser, Peter Schwandt, Gerda-Maria Haas, Uli C. Broedl, Michael Lehrke, Klaus G. Parhofer

Journal:

Clinical Biochemistry

Année:

2009

Langue:

english

Fichier:

PDF, 193 KB

english, 2009

20

Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature

Klaus H. Metzeler, Stefan Boeck, Birgit Christ, Andreas Hausmann, Hans-Joachim Stemmler, Klaus G. Parhofer, Helmut Ostermann, Wolfgang Hiddemann, Jan Braess

Journal:

Leukemia Research

Année:

2009

Langue:

english

Fichier:

PDF, 288 KB

english, 2009

21

Comparison of current guidelines for primary prevention of coronary heart disease

Uli C. Broedl, Hans-Christian Geiss, Klaus G. Parhofer

Journal:

Journal of General Internal Medicine

Année:

2003

Langue:

english

Fichier:

PDF, 153 KB

english, 2003

22

Influence of Atorvastatin Versus Simvastatin on Fibrinogen and Other Hemorheological Parameters in Patients with Severe Hypercholesterolemia Treated with Regular Low-Density Lipoprotein Immunoadsorption Apheresis

Carsten Otto, H. Christian Geiss, Markus G. Donner, Klaus G. Parhofer, Peter Schwandt

Journal:

Therapeutic Apheresis and Dialysis

Année:

2000

Langue:

english

Fichier:

PDF, 192 KB

english, 2000

23

Relative roles of the different Pax6 domains for pancreatic alpha cell development

Petra Dames, Ramona Puff, Michaela Weise, Klaus G Parhofer, Burkhard Göke, Magdalena Götz, Jochen Graw, Jack Favor, Andreas Lechner

Journal:

BMC Developmental Biology

Année:

2010

Langue:

english

Fichier:

PDF, 1.62 MB

english, 2010

24

Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial

Klaus Empen, Robert JA Frost, H Christian Geiss, Carsten Otto, Klaus G Parhofer

Journal:

Cardiovascular Diabetology

Année:

2003

Langue:

english

Fichier:

PDF, 500 KB

english, 2003

25

Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome

Uli C Broedl, Michael Lehrke, Elisabeth Fleischer-Brielmaier, Anne B Tietz, Jutta M Nagel, Burkhard Göke, Peter Lohse, Klaus G Parhofer

Journal:

Cardiovascular Diabetology

Année:

2006

Langue:

english

Fichier:

PDF, 523 KB

english, 2006

26

Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study

Klaus G Parhofer, Felix Münzel, Michael Krekler

Journal:

Cardiovascular Diabetology

Année:

2007

Langue:

english

Fichier:

PDF, 493 KB

english, 2007

27

Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitus

Hannes M Findeisen, Sabine Weckbach, Renée G Stark, Maximilian F Reiser, Stefan O Schoenberg, Klaus G Parhofer

Journal:

Cardiovascular Diabetology

Année:

2010

Langue:

english

Fichier:

PDF, 936 KB

english, 2010

28

Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort

Uwe Zeymer, Klaus G. Parhofer, David Pittrow, Christiane Binz, Markus Schwertfeger, Tobias Limbourg, Joachim Röther

Journal:

Clinical Research in Cardiology

Année:

2009

Langue:

english

Fichier:

PDF, 303 KB

english, 2009

29

Lipoprotein (a) metabolism estimated by nonsteady-state kinetics

Klaus G. Parhofer, Thomas Demant, Michael M. Ritter, H. Christian Geiss, Markus Donner, Peter Schwandt

Journal:

Année:

1999

Langue:

english

Fichier:

PDF, 166 KB

english, 1999

30

Limited preanalytical requirements for insulin measurement

Michael Vogeser, Klaus G. Parhofer

Journal:

Clinical Biochemistry

Année:

2005

Langue:

english

Fichier:

PDF, 106 KB

english, 2005

31

Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons

Michael Vogeser, Daniel König, Ingrid Frey, Hans-Georg Predel, Klaus Georg Parhofer, Aloys Berg

Journal:

Clinical Biochemistry

Année:

2007

Langue:

english

Fichier:

PDF, 255 KB

english, 2007

32

Efficacy and Safety of a New Whole-blood Low-density Lipoprotein Apheresis System (Liposorber D) in Severe Hypercholesterolemia

Carsten Otto, Peter Kern, Rolf Bambauer, Stefan Kallert, Peter Schwandt, Klaus G. Parhofer

Journal:

Artificial Organs

Année:

2003

Langue:

english

Fichier:

PDF, 66 KB

english, 2003

33

Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia

Parhofer, Klaus

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 223 KB

english, 2012

34

Effect of Atorvastatin (10 mg/day) on Glucose Metabolism in Patients With the Metabolic Syndrome

Sebastian Huptas, Hans-Christian Geiss, Carsten Otto, Klaus Georg Parhofer

Journal:

The American Journal of Cardiology

Année:

2006

Langue:

english

Fichier:

PDF, 105 KB

english, 2006

35

Cardiovascular Event Rates in Diabetic and Nondiabetic Individuals With and Without Established Atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)

Michel Krempf, Klaus G. Parhofer, Ph. Gabriel Steg, Deepak L. Bhatt, E. Magnus Ohman, Joachim Röther, Shinya Goto, Blandine Pasquet, Peter W.F. Wilson

Journal:

The American Journal of Cardiology

Année:

2010

Langue:

english

Fichier:

PDF, 253 KB

english, 2010

36

Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia

Robert J.A Frost, Carsten Otto, H.Christian Geiss, Peter Schwandt, Klaus G Parhofer

Journal:

The American Journal of Cardiology

Année:

2001

Langue:

english

Fichier:

PDF, 683 KB

english, 2001

37

Knockdown of Pdcd4 results in induction of proprotein convertase 1/3 and potent secretion of chromogranin A and secretogranin II in a neuroendocrine cell line

Brigitte Lankat-Buttgereit, Sabine Müller, Harald Schmidt, Klaus G. Parhofer, Thomas M. Gress, Rüdiger Göke

Journal:

Biology of the Cell

Année:

2008

Langue:

english

Fichier:

PDF, 525 KB

english, 2008

38

Drug Therapy of Severe Hypercholesterolemia in Patients with Coronary Artery Disease

Klaus G. Parhofer, Werner O. Richter, Peter Schwandt

Journal:

Artificial Organs

Année:

1996

Langue:

english

Fichier:

PDF, 618 KB

english, 1996

39

Malacoplakia in a renal transplant recipient

Thomas Pusl, Max Weiss, Bertram Hartmann, Thorsten Wendler, Klaus Parhofer, Henrik Michaely

Journal:

European Journal of Internal Medicine

Année:

2006

Langue:

english

Fichier:

PDF, 135 KB

english, 2006

40

Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis

Thomas Pusl, Gerald U. Denk, Klaus G. Parhofer, Ulrich Beuers

Journal:

Journal of Hepatology

Année:

2006

Langue:

english

Fichier:

PDF, 334 KB

english, 2006

41

In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects

Regina E. Dinkel, P. Hugh R. Barrett, Thomas Demant, Klaus G. Parhofer

Journal:

Nutrition, Metabolism and Cardiovascular Diseases

Année:

2006

Langue:

english

Fichier:

PDF, 230 KB

english, 2006

42

Low-density lipoprotein-apolipoprotein B metabolism following apheresis: Simulation studies of mass changes and tracer kinetics

P.Hugh R. Barrett, Klaus G. Parhofer

Journal:

Année:

1998

Langue:

english

Fichier:

PDF, 645 KB

english, 1998

43

Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis

Markus G. Donner, Klaus G. Parhofer, Werner O. Richter, Peter Schwandt

Journal:

Année:

1999

Langue:

english

Fichier:

PDF, 686 KB

english, 1999

44

The Prevention Education Program (PEP). A Prospective Study of the Efficacy of Family-Oriented Life Style Modification in the Reduction of Cardiovascular Risk and Disease: Design and Baseline Data

Peter Schwandt, Hans C. Geiß, Michael M. Ritter, Christa Üblacker, Klaus G. Parhofer, Carsten Otto, Ester Laubach, Markus G. Donner, Gerda-M. Haas, Werner O. Richter

Journal:

Journal of Clinical Epidemiology

Année:

1999

Langue:

english

Fichier:

PDF, 333 KB

english, 1999

45

Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake

Marcus J. Mussner, Klaus G. Parhofer, Klaus von Bergmann, Peter Schwandt, Uli Broedl, Carsten Otto

Journal:

Année:

2002

Langue:

english

Fichier:

PDF, 57 KB

english, 2002

46

PANORAMA: A European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus—Study design

Clare Bradley, Pedro de Pablos-Velasco, Klaus G. Parhofer, Eveline Eschwège, Linda Gönder-Frederick, Dominique Simon

Journal:

Primary Care Diabetes

Année:

2011

Langue:

english

Fichier:

PDF, 309 KB

english, 2011

47

Long-term reduction of C-reactive protein concentration by regular LDL apheresis

Carsten Otto, H.Christian Geiss, Klaus Empen, Klaus G. Parhofer

Journal:

Atherosclerosis

Année:

2004

Langue:

english

Fichier:

PDF, 76 KB

english, 2004

48

Interferon-α-induced agranulocytosis in a patient on long-term clozapine therapy

Robert M. Hoffmann, Stefan Ott, Klaus G. Parhofer, Reiner Bartl, Gerd R. Pape

Journal:

Journal of Hepatology

Année:

1998

Langue:

english

Fichier:

PDF, 51 KB

english, 1998

49

The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects

Jutta M. Nagel, Anne B. Tietz, Burkhard Göke, Klaus G. Parhofer

Journal:

Année:

2006

Langue:

english

Fichier:

PDF, 186 KB

english, 2006

50

Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins

H. Christian Geiss, Carsten Otto, Klaus G. Parhofer

Journal:

Année:

2006

Langue:

english

Fichier:

PDF, 179 KB

english, 2006